Evidence map›Paper›PMID 34680381›Full record

ArticleCancers2021

Radiation-Induced Fibrotic Tumor Microenvironment Regulates Anti-Tumor Immune Response.

Jae-Kyung Nam, Ji-Hee Kim, Min-Sik Park, Eun Ho Kim, Joon Kim, Yoon-Jin Lee

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. 2-Methoxyestradiol Inhibits Radiation-Induced Skin Injuries.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jae-Kyung NamDivision of Radiation Biomedical Research, Korea Institute of Radiologic and Medical Sciences, Seoul 01812, Korea.
Ji-Hee KimDivision of Radiation Biomedical Research, Korea Institute of Radiologic and Medical Sciences, Seoul 01812, Korea.
Min-Sik ParkDivision of Radiation Biomedical Research, Korea Institute of Radiologic and Medical Sciences, Seoul 01812, Korea.
Eun Ho KimDepartment of Biochemistry, School of Medicine, Daegu Catholic University, Nam-gu, Daegu 42472, Korea.
Joon KimLaboratory of Biochemistry, Division of Life Sciences, Korea University, Seoul 02841, Korea.
Yoon-Jin LeeDivision of Radiation Biomedical Research, Korea Institute of Radiologic and Medical Sciences, Seoul 01812, Korea.
Korea University · KRDaegu Catholic University · KRKorea Institute of Radiological and Medical Sciences · KR

Funding

National Research Foundation of Korea NRF-2020M2D9A2093964 ,NRF-2020R1A2B5B02002709,KIRAMS, 50531-2021
6 · The paper itself

Abstract

High linear energy transfer (LET) radiation, such as neutron radiation, is considered more effective for the treatment of cancer than low LET radiation, such as X-rays. We previously reported that X-ray irradiation induced endothelial-to-mesenchymal transition (EndMT) and profibrotic changes, which contributed to the radioresistance of tumors. However, this effect was attenuated in tumors of endothelial-specific Trp53-knockout mice. Herein, we report that compared to X-ray irradiation, neutron radiation therapy reduced collagen deposition and suppressed EndMT in tumors. In addition to the fewer fibrotic changes, more cluster of differentiation (CD8)-positive cytotoxic T cells were observed in neutron-irradiated regrowing tumors than in X-ray-irradiated tumors. Furthermore, lower programmed death-ligand 1 (PD-L1) expression was noted in the former. Endothelial-specific Trp53 deletion suppressed fibrotic changes within the tumor environment following both X-ray and neutron radiation therapy. In particular, the upregulation in PD-L1 expression after X-ray radiation therapy was significantly dampened. Our findings suggest that compared to low LET radiation therapy, high LET radiation therapy can efficiently suppress profibrotic changes and enhance the anti-tumor immune response, resulting in delayed tumor regrowth.

Indexed as

anti-tumor immune responsefibrotic tumor microenvironmenthigh linear energy transferneutron radiation therapyprogrammed death-ligand 1X-ray radiation therapy

Identifiers

PMID34680381
PMCPMC8533839
OpenAlexW3206261210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.